Impact Factor
3.53
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.71
507 total citations
h5-index
28
h5 depth signal
Cited share
76.1%
118 of 155
Total citations
507
Citation footprint
Metric signal
3.33
External metric anchor
Self-citation
0.2%
1 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
316
Italy
122
Egypt
62
United States
39
Poland
31
Citing Fields of Research
Immunology
216
Noncoding RNA
82
Allergies
77
Phytochemicals
57
Hematology
49
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,578
Articles tracked across the journal lifetime
Indexed publication set
155
118 cited publications
Last 12 months
26
2.6 publications/month
Open access share
100.0%
26 OA publications in the last year
Leading citing country
China
316 citing publications
Leading citing field
Immunology
216 citing publications
Latest tracked publication
14 October 2026
10 recent records available
Coverage & Indexing History
v16n1, Jan./Apr. 2003-
v16n1, Jan./Apr. 2003-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Immunology
Broad Categories
Allergy and Immunology
Pathology
Pharmacology
Musculoskeletal Disorders
Immunology
Cell Differentiation & Development
Cancer, Autophagy & Apoptosis
Hematology
Virology
Noncoding RNA
MeSH Descriptors
Immune System Diseases
Immune System
Immunity
Pharmacology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1177/03946320261497604
Open DOI
Reframing the gut-lung axis: Microbiota dysbiosis, immune-redox regulation, and the potential role of vitamin C
The respiratory system is continuously exposed to environmental antigens, pathogens, and pollutants, requiring tightly regulated immunity to balance inflammation and host defense. Increasing evidence indicates that the microbiome—within ...
02
DOI 10.1177/03946320261472669
Open DOI
Atypical cytokine release syndrome induced by carboplatin: The first described case report
Introduction: Hypersensitivity reactions to carboplatin include type I reactions, mixed reactions, and delayed reactions. Case report: We report a case of an atypical cytokine release syndrome induced by carboplatin in a patient with bre...
03
DOI 10.1177/03946320261486727
Open DOI
Integrated transcriptomic and immunogenomic analysis unravels the immunological functions and prognostic landscape of WD repeat domain 76
Background: WD Repeat Domain 76 (WDR76) plays a potential role in cellular regulation; however, its comprehensive landscape across human malignancies and its specific biological function in hepatocellular carcinoma (HCC) remain largely u...
04
DOI 10.1177/03946320261476799
Open DOI
Beyond antibiotic prophylaxis: A scoping review of infective endocarditis prevention in the device era
Infective endocarditis (IE) remains a severe condition associated with significant morbidity and mortality. Dental procedures involving manipulation of gingival tissue or the periapical region may cause transient bacteremia, making preve...
05
DOI 10.1177/03946320261471029
Open DOI
Diagnostic preparedness for Inborn Errors of Immunity among primary care and non-immunology healthcare professionals in Kazakhstan: A cross-sectional questionnaire based study
Introduction/Objectives: Inborn Errors of Immunity (IEIs) are rare disorders in which delayed diagnosis leads to significant morbidity and mortality. Early recognition depends largely on primary care and non-immunology healthcare profess...
06
DOI 10.1177/03946320261474427
Open DOI
Assessing tumor heterogeneity and FLOT/FOLFOX-induced alterations in cancer stem cells and cancer immune checkpoint molecules using patient-derived tumor organoids
Background: Gastric cancer is a deadly disease with poor prognosis and unfavorable therapeutic outcomes. It is known that a major cause of treatment failure for gastric cancer is related to tumor heterogeneity. However, it is difficult t...
07
DOI 10.1177/03946320261465568
Open DOI
Inflammatory and neuroinjury blood biomarkers across COVID-19 severity groups in individuals with persistent neurological symptoms
Persistent neurological symptoms such as cognitive impairment, fatigue, and neuropsychiatric disturbances are increasingly reported in patients with long COVID, with chronic neuroinflammation and neuronal injury proposed as potential con...
08
DOI 10.1177/03946320261450099
Open DOI
Glycolysis and neutrophil extracellular traps in atherosclerosis: Mechanisms, association, and therapeutic strategies
Atherosclerosis (AS) is a chronic inflammatory disorder of the medium and large arteries, characterized by lipid accumulation within the arterial wall and a sustained inflammatory milieu, and it remains a leading cause of cardiovascular ...
09
DOI 10.1177/03946320261451393
Open DOI
Development of RNase P ribozyme-based therapy against oral herpesvirus infections by HSV-1 and KSHV
Infections with human herpesviruses are known to be associated with oral lesions and other oral complications. For example, herpes simplex virus 1 (HSV-1) is the causative agent for cold sores. Kaposi’s sarcoma-associated herpesvirus (KS...
10
DOI 10.1177/03946320261438337
Open DOI
Liposomal nanotherapeutics for cancer treatment: Targeted delivery and immunotherapy
Cancer has become a major global health crisis and the second leading cause of death worldwide. With over 270 different types, it is estimated to claim 13 million lives by 2030. The complex pathophysiology of cancer, with its diverse gen...
Bibliographical & Catalog Notes
Description based on: Vol. 1, no. 3 (Sept.-Dec. 1988); title from cover.
Place of publication varies.
Latest issue consulted: Vol. 15, no. 3 (Sept./Dec. 2002).
Also issued online.
v. 16, no. 1 (Jan-Apr 2003)20030311 Notice published Printed on acid-free paper